SUMNER C. KRAFT, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
There is a growing list of tumor-associated fetal substances that show diagnostic promise and may in time have immunotherapeutic and prophylactic value (1, 2). Malignancies of the digestive system have received special attention in this regard, especially since 1965, when Gold and Freedman (3) identified a tumor-specific glycoprotein antigen in human colonic carcinomas. This so-called carcinoembryonic antigen (CEA) is also present in other adenocarcinomas of entodermally derived digestive system epithelium, as well as in human fetal and embryonic gut, pancreas, and liver during the first two trimesters of pregnancy (4). The antigen is a predominantly carbohydrate material with a molecular
KRAFT SC. "Humors from Tumors": Carcinoembryonic Antigen, Alpha-Fetoprotein, and Digestive System Cancer. Ann Intern Med. 1972;76:502–504. doi: 10.7326/0003-4819-76-3-502
Download citation file:
Published: Ann Intern Med. 1972;76(3):502-504.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use